Herpes Simplex Viruses

news

Key insights into vaccine development for herpesviruses

27 February 2024 | By Drug Target Review

Researchers found that the D48 antibody neutralised HSV-1 virus infection, which could lead to broad-spectrum drug and vaccine development.

article

Emerging trends in biotherapeutic development

11 April 2022 | By Dr Andrew Bradbury (Specifica), Dr Bryan Jones (Eli Lilly & Company), Dr Erica Ollmann Saphire (La Jolla Institute for Immunology), Dr Gary Cohen (University of Pennsylvania), Dr Molly Gibson (Generate Biomedicines)

The COVID-19 pandemic has placed a spotlight on the discovery and development of biotherapeutics, for both the treatment and prevention of diseases. In this article, industry experts discuss the emerging trends they see in biotherapeutic development and how they predict the field will evolve in the near future.

news

Brain organoids reveal mechanisms of virus-induced microcephaly

16 April 2021 | By Victoria Rees (Drug Target Review)

Researchers have shown how different viruses such as HSV-1 and Zika can lead to microcephaly using brain organoids.